Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 46 Records) |
Query Trace: Breast Neoplasms and BRAF[original query] |
---|
Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium. NPJ breast cancer 2016 2 . Ruiz-Narváez Edward A, Lunetta Kathryn L, Hong Chi-Chen, Haddad Stephen, Yao Song, Cheng Ting-Yuan David, Bensen Jeannette T, Bandera Elisa V, Haiman Christopher A, Troester Melissa A, Ambrosone Christine B, Rosenberg Lynn, Palmer Julie |
BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model. Asian Pacific journal of cancer prevention : APJCP 2017 8 18 (8): 2209-2213. Patra Satyajit, Young Vanesa, Llewellyn Leslie, Senapati Jitendra N, Mathew Jes |
Clinical Pharmacokinetics of Vemurafenib. Clinical pharmacokinetics 2017 Mar . Zhang Weijiang, Heinzmann Dominik, Grippo Joseph |
[Exploratory study of circulating tumor DNA detection in early breast cancer: an analysis of 75 next-generation sequencing results]. Zhonghua wai ke za zhi [Chinese journal of surgery] 2017 Nov 55 (11): 847-852. Zhou B, Xin L, Xu L, Liu Y H, Zhang M M, Jing R L, Liang X Y, Cao S |
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases. Oncotarget 2018 Apr 9 (29): 20617-20630. De Mattos-Arruda Leticia, Ng Charlotte K Y, Piscuoglio Salvatore, Gonzalez-Cao Maria, Lim Raymond S, De Filippo Maria R, Fusco Nicola, Schultheis Anne M, Ortiz Carolina, Viteri Santiago, Arias Alexandra, Macedo Gabriel S, Oliveira Mafalda, Gomez Patricia, Teixidó Cristina, Nuciforo Paolo, Peg Vicente, Saura Cristina, Ramon Y Cajal Santiago, Casas Francesc Tresserra, Weigelt Britta, Cortes Javier, Seoane Joan, Reis-Filho Jorge |
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00. Breast cancer research and treatment 2018 Mar . Munzone Elisabetta, Gray Kathryn P, Fumagalli Caterina, Guerini-Rocco Elena, Láng István, Ruhstaller Thomas, Gianni Lorenzo, Kammler Roswitha, Viale Giuseppe, Di Leo Angelo, Coates Alan S, Gelber Richard D, Regan Meredith M, Goldhirsch Aron, Barberis Massimo, Colleoni Mar |
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations; Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer. The New England journal of medicine 2018 10 379 (16): 1585. Authors are not available |
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin. Molecular cytogenetics 2018 1 11 6. La Starza Roberta, Pierini Tiziana, Pastorino Lorenza, Albi Elisa, Matteucci Caterina, Crescenzi Barbara, Sportoletti Paolo, Covarelli Piero, Falzetti Franca, Roti Giovanni, Ascani Stefano, Mecucci Cristi |
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 4 25 (13): 3986-3995. Loibl Sibylle, Treue Denise, Budczies Jan, Weber Karsten, Stenzinger Albrecht, Schmitt Wolfgang D, Weichert Wilko, Jank Paul, Furlanetto Jenny, Klauschen Frederick, Karn Thomas, Pfarr Nicole, von Minckwitz Gunter, Möbs Markus, Jackisch Christian, Sers Christine, Schneeweiss Andreas, Fasching Peter A, Schem Christian, Hummel Michael, van Mackelenbergh Marion, Nekljudova Valentina, Untch Michael, Denkert Carst |
Genetic Profiling of Breast Cancer with and Without Preexisting Metabolic Disease. Translational oncology 2019 12 13 (2): 245-253. Jing Wenjiang, Li Ling, Zhang Xiumei, Wu Shouxin, Zhao Jiangman, Hou Qunxing, Wu Haotian, Ma Wu, Li Shuheng, Liu Huimin, Yang Binh |
Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors. International journal of molecular sciences 2019 Jan 20 (3): . Lopez Gianluca, Costanza Jole, Colleoni Matteo, Fontana Laura, Ferrero Stefano, Miozzo Monica, Fusco Nico |
Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial. JCO precision oncology 2020 9 2 . Basse Clémence, Morel Claire, Callens Céline, Pierron Gaëlle, Servois Vincent, Vincent-Salomon Anne, Jobard Aude, Alt Marie, Ricci Francesco, Loirat Delphine, Sablin Marie-Paule, Bretagne Marie, Saint-Ghislain Mathilde, Hescot Ségolène, Gonçalves Anthony, Tredan Olivier, Dubot Coraline, Gavoille Céline, Delord Jean-Pierre, Campone Mario, Isambert Nicolas, Belin Lisa, Bieche Ivan, Kamal Maud, Le Tourneau Christop |
Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients. Breast cancer research and treatment 2020 Aug . Skriver Signe Korsgaard, Jensen Maj-Britt, Eriksen Jens-Ole, Ahlborn Lise Barlebo, Knoop Ann Soegaard, Rossing Maria, Ejlertsen Bent, Laenkholm Anne-Vibe |
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers. Journal of hematology & oncology 2020 2 13 (1): 13. Coussy F, El Botty R, Lavigne M, Gu C, Fuhrmann L, Briaux A, de Koning L, Dahmani A, Montaudon E, Morisset L, Huguet L, Sourd L, Painsec P, Chateau-Joubert S, Larcher T, Vacher S, Melaabi S, Salomon A Vincent, Marangoni E, Bieche |
Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients. BMC cancer 2020 Jan 20 (1): 72. Manoharan Vahinipriya, Karunanayake Eric Hamilton, Tennekoon Kamani Hemamala, De Silva Sumadee, Imthikab Ahamed Ilyas Ahamed, De Silva Kanishka, Angunawela Preethika, Vishwakula Sameera, Lunec Jo |
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA). Breast cancer research and treatment 2020 Nov . Clifton Katherine, Luo Jingqin, Tao Yu, Saam Jennifer, Rich Thereasa, Roshal Anna, Frith Ashley, Rigden Caron, Ademuyiwa Foluso, Weilbaecher Katherine, Hernandez-Aya Leonel, Peterson Lindsay L, Bagegni Nusayba, Suresh Rama, Bose Ron, Opyrchal Mateusz, Wildes Tanya M, Ma Cynth |
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations. Cancer research and treatment 2021 5 54 (1): 30-39. Choi Yoon Ji, Choi Jung Yoon, Kim Ju Won, Lim Ah Reum, Lee Youngwoo, Chang Won Jin, Lee Soohyeon, Sung Jae Sook, Chung Hee-Joon, Lee Jong Won, Kang Eun Joo, Kim Jung Sun, Lim Taekyu, Kim Hye Sook, Kim Yu Jung, Ahn Mi Sun, Kim Young Saing, Park Ji Hyun, Lim Seungtaek, Cho Sung Shim, Cho Jang Ho, Shin Sang Won, Park Kyong Hwa, Kim Yeul Ho |
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer. NPJ breast cancer 2021 Apr 7 (1): 43. da Silva Edaise M, Selenica Pier, Vahdatinia Mahsa, Pareja Fresia, Da Cruz Paula Arnaud, Ferrando Lorenzo, Gazzo Andrea M, Dopeso Higinio, Ross Dara S, Bakhteri Ariya, Riaz Nadeem, Chandarlapaty Sarat, Razavi Pedram, Norton Larry, Wen Hannah Y, Brogi Edi, Weigelt Britta, Zhang Hong, Reis-Filho Jorge |
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data. Oncoimmunology 2021 2 10 (1): 1865653. Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair, |
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
[Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2021 10 43 (10): 1088-1093. Tang X J, Yang M Y, Zhu L Z, Xu D, Yuan |
Thyroid carcinoma associated with other primary neoplasms, a single center study. Medicine and pharmacy reports 2022 9 95 (3): 275-281. Gabora Katalin, B?l?cescu Ovidiu, Trifa Adrian, Morariu Ana Maria, Pop Bogdan, Vi?an Simona, Fetica Bogdan, Piciu Andra, Piciu Doi |
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population. Frontiers in oncology 2022 5 12 842787. Ni Shujuan, Wang Xin, Chang Jinjia, Sun Hui, Weng Weiwei, Wang Xu, Tan Cong, Zhang Meng, Wang Lei, Huang Zhaohui, Huang Dan, Xu Midie, Sheng Wei |
KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer. Journal of cancer research and clinical oncology 2022 4 . Shimozaki Keitaro, Shinozaki Eiji, Yamamoto Noriko, Imamura Yu, Osumi Hiroki, Nakayama Izuma, Wakatsuki Takeru, Ooki Akira, Takahari Daisuke, Ogura Mariko, Chin Keisho, Watanabe Masayuki, Yamaguchi Kens |
Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2023 9 . Sibel Osman, Nesibe Kahraman Çetin, ?brahim Halil Erdo?du, ?brahim Meteo? |
mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women's Circle of Health Study. Cancer causes & control : CCC 2023 2 . Ilozumba Mmadili N, Yaghjyan Lusine, Datta Susmita, Zhao Jinying, Hong Chi-Chen, Lunetta Kathryn L, Zirpoli Gary, Bandera Elisa V, Palmer Julie R, Yao Song, Ambrosone Christine B, Cheng Ting-Yuan Dav |
Druggable genomic landscapes of high-grade gliomas. Frontiers in medicine 2023 12 10 1254955. Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, , Jenna Canzoniero, Stuart A Grossman, Kristen Marrone, Karisa C Schreck, Valsamo Anagnost |
The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Annals of oncology : official journal of the European Society for Medical Oncology 2023 10 . T Fulton-Ward, G Middlet |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: